Ni Q, Miao Y, Li X, Yin Z, Huang H, Shi G
Mol Biotechnol. 2024; .
PMID: 38676754
DOI: 10.1007/s12033-024-01143-4.
Wang D, Zou F, Li Y, Hu J, Gao L
Mol Ther Oncol. 2024; 32(1):200759.
PMID: 38596298
PMC: 10869760.
DOI: 10.1016/j.omton.2024.200759.
Lee I, Lee S, Kang B, Lee J, Jung J, Park H
Breast Cancer Res Treat. 2024; 205(1):181-191.
PMID: 38279017
DOI: 10.1007/s10549-023-07198-2.
Wang Z, Castro N, Bernstein A, Wolosin J
Cell Signal. 2023; 113:110963.
PMID: 37931692
PMC: 10959399.
DOI: 10.1016/j.cellsig.2023.110963.
He M, Liang J, Shen Y, Zhang C, Yang K, Liu L
Molecules. 2023; 28(14).
PMID: 37513270
PMC: 10386263.
DOI: 10.3390/molecules28145398.
Targeted Pyroptosis Is a Potential Therapeutic Strategy for Cancer.
Wu H, Qian D, Bai X, Sun S
J Oncol. 2022; 2022:2515525.
PMID: 36467499
PMC: 9715319.
DOI: 10.1155/2022/2515525.
Copy number variants suggest different molecular pathways for the pathogenesis of bladder exstrophy.
Nordenskjold A, Arkani S, Pettersson M, Winberg J, Cao J, Fossum M
Am J Med Genet A. 2022; 191(2):378-390.
PMID: 36349425
PMC: 10100507.
DOI: 10.1002/ajmg.a.63031.
Computational exploration of maternal embryonic leucine zipper kinase (MELK) as a cancer drug target.
Almansour N
Saudi J Biol Sci. 2022; 29(7):103335.
PMID: 35769060
PMC: 9235044.
DOI: 10.1016/j.sjbs.2022.103335.
Assessing genomic diversity and signatures of selection in Pinan cattle using whole-genome sequencing data.
Zhang S, Yao Z, Li X, Zhang Z, Liu X, Yang P
BMC Genomics. 2022; 23(1):460.
PMID: 35729510
PMC: 9215082.
DOI: 10.1186/s12864-022-08645-y.
Identifying key genes and screening therapeutic agents associated with diabetes mellitus and HCV-related hepatocellular carcinoma by bioinformatics analysis.
Sufyan M, Ashfaq U, Ahmad S, Noor F, Saleem M, Aslam M
Saudi J Biol Sci. 2021; 28(10):5518-5525.
PMID: 34588861
PMC: 8459114.
DOI: 10.1016/j.sjbs.2021.07.068.
A synthetic lethal screen identifies HDAC4 as a potential target in MELK overexpressing cancers.
Zhou L, Zheng S, Rosas Bringas F, Bakker B, Simon J, Bakker P
G3 (Bethesda). 2021; 11(12).
PMID: 34550356
PMC: 8664443.
DOI: 10.1093/g3journal/jkab335.
Comprehensive Bioinformatics Analysis of mRNA Expression Profiles and Identification of a miRNA-mRNA Network Associated with the Pathogenesis of Low-Grade Gliomas.
Wang M, Cui Y, Cai Y, Jiang Y, Peng Y
Cancer Manag Res. 2021; 13:5135-5147.
PMID: 34234557
PMC: 8254561.
DOI: 10.2147/CMAR.S314011.
Role of Stress-Survival Pathways and Transcriptomic Alterations in Progression of Colorectal Cancer: A Health Disparities Perspective.
Basnet U, Patil A, Kulkarni A, Roy S
Int J Environ Res Public Health. 2021; 18(11).
PMID: 34063993
PMC: 8196775.
DOI: 10.3390/ijerph18115525.
Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function.
van der Kooi A, van Dijk M, Broer L, van den Berg M, Laven J, van Leeuwen F
Hum Reprod. 2021; 36(4):1120-1133.
PMID: 33582778
PMC: 7970730.
DOI: 10.1093/humrep/deaa342.
MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma.
Tang Q, Li W, Zheng X, Ren L, Liu J, Li S
Signal Transduct Target Ther. 2020; 5(1):279.
PMID: 33262323
PMC: 7708490.
DOI: 10.1038/s41392-020-00288-3.
Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Chen X, Liao L, Li Y, Huang H, Huang Q, Deng S
Biomed Res Int. 2020; 2020:7653506.
PMID: 33102593
PMC: 7568806.
DOI: 10.1155/2020/7653506.
PIG-1 MELK-dependent phosphorylation of nonmuscle myosin II promotes apoptosis through CES-1 Snail partitioning.
Wei H, Lambie E, Osorio D, Carvalho A, Conradt B
PLoS Genet. 2020; 16(9):e1008912.
PMID: 32946434
PMC: 7527206.
DOI: 10.1371/journal.pgen.1008912.
Maternal embryonic leucine zipper kinase: A novel biomarker and a potential therapeutic target in lung adenocarcinoma.
Chen S, Lu Z, Chen X, Wu X, Tu H, Yu L
Oncol Lett. 2020; 20(5):147.
PMID: 32934715
PMC: 7471708.
DOI: 10.3892/ol.2020.12010.
Identification of potential hub genes associated with the pathogenesis and prognosis of hepatocellular carcinoma via integrated bioinformatics analysis.
Meng Z, Wu J, Liu X, Zhou W, Ni M, Liu S
J Int Med Res. 2020; 48(7):300060520910019.
PMID: 32722976
PMC: 7391448.
DOI: 10.1177/0300060520910019.
Maternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in osteosarcoma.
Jeddo S, Wei X, Li K, Li X, Yang Q, Dongol S
Oncol Rep. 2020; 44(3):1037-1048.
PMID: 32705239
PMC: 7388486.
DOI: 10.3892/or.2020.7686.